Eli Lilly and Company (LLY)

Gross profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Gross profit (ttm)	US$ in thousands	27,078,800	24,337,900	23,085,700	21,085,900	19,527,400	17,930,500	15,614,600	14,446,400	15,019,800	15,131,200	15,333,700	14,979,300	13,918,800	14,047,300	13,068,300	12,760,700	12,627,700	13,481,900	13,565,700	13,676,300
Revenue (ttm)	US$ in thousands	45,042,700	40,863,300	38,922,800	35,932,100	34,124,100	32,072,500	29,515,500	27,691,400	28,541,400	29,239,500	29,070,700	29,322,800	28,318,400	27,758,500	26,726,300	25,485,600	24,539,800	23,213,800	22,949,800	23,087,100
Gross profit margin		60.12%	59.56%	59.31%	58.68%	57.22%	55.91%	52.90%	52.17%	52.62%	51.75%	52.75%	51.08%	49.15%	50.61%	48.90%	50.07%	51.46%	58.08%	59.11%	59.24%

December 31, 2024 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $27,078,800K ÷ $45,042,700K
= 60.12%

The gross profit margin of Eli Lilly and Company has displayed fluctuating trends over the periods provided. Starting at 59.24% in March 2020, the margin slightly decreased to 58.08% by September 2020. A more significant drop was seen by the end of December 2020, standing at 51.46%. The margin continued to decrease in the following months, reaching a low of 48.90% in June 2021.

From September 2021 onwards, there was a gradual recovery in the gross profit margin, with fluctuations along the way. By December 2024, the gross profit margin had improved to 60.12%, showing a positive trend in the company's ability to generate profit from its core business operations.

Overall, the gross profit margin of Eli Lilly and Company has shown resilience and a tendency to improve over the periods analyzed, indicating potential strength in the company's pricing strategies, cost management, and revenue generation capabilities.